Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate

Vanessa Cavieres1, Karla Valdes1, Brayan Moreno1

  • 1Departamento de Ciencias Basicas Biomedicas, Facultad de Ciencias de la Salud, Universidad de Talca Talca, Chile.

Insights

Mild dyslipidemia in apoE(+/-) mice causes endothelial dysfunction and a pro-inflammatory state. This occurs before atherosclerosis develops, indicated by reduced nitric oxide (NO) and increased inflammatory markers.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Function
  • Dyslipidemia Research

Background:

  • Atherosclerosis is a chronic inflammatory disease affecting major arteries.
  • Endothelial dysfunction is a critical early event preceding atheroma formation.
  • Mild dyslipidemia may trigger pro-inflammatory processes impacting vascular health.

Purpose of the Study:

  • To investigate endothelial dysfunction in apolipoprotein E-deficient (apoE(+/-)) mice as a model of mild dyslipidemia.
  • To determine if early dyslipidemia induces inflammation and alters nitric oxide (NO) production.
  • To assess vascular reactivity and inflammatory markers in the absence of overt atherosclerosis.

Main Methods:

  • Vascular reactivity studies using isolated aortic rings from apoE(+/-) and wild-type mice.
  • Measurement of vasodilation in response to acetylcholine (endothelium-dependent).
  • Quantification of plasma nitrite/nitrate (NO metabolites), endothelial nitric oxide synthase (eNOS), and inflammatory cytokines (TNF-α, MCP-1, IL-6).

Main Results:

  • ApoE(+/-) mice exhibited increased aortic tension and diminished vasorelaxation to acetylcholine.
  • Significant reductions in plasma NO metabolites and eNOS levels were observed in apoE(+/-) mice.
  • Elevated levels of MCP-1 and IL-6, but not TNF-α, were found in apoE(+/-) mice, indicating a pro-inflammatory state without atheroma.

Conclusions:

  • Mild dyslipidemia in apoE(+/-) mice induces endothelial dysfunction.
  • This dysfunction is associated with a pro-inflammatory state and impaired nitric oxide bioavailability.
  • These findings highlight early vascular changes preceding atherosclerosis development.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
653
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
604
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
13.7K